At the end of the latest market close, AzurRx BioPharma Inc. (AZRX) was valued at $0.82. In that particular session, Stock kicked-off at the price of $0.935 while reaching the peak value of $1.02 and lowest value recorded on the day was $0.8881. The stock current value is $0.92.
Recently in News on January 8, 2021, AzurRx BioPharma CEO Issues Letter to Shareholders. AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, today issued the following letter to its shareholders and the investment community from James Sapirstein, President and Chief Executive Officer. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
AzurRx BioPharma Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.0200 on 01/11/21, with the lowest value was $0.7900 for the same time period, recorded on 01/07/21.
AzurRx BioPharma Inc. (AZRX) full year performance was -46.37%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AzurRx BioPharma Inc. shares are logging -52.41% during the 52-week period from high price, and 148.74% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.37 and $1.94.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 13574667 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the AzurRx BioPharma Inc. (AZRX) recorded performance in the market was -4.90%, having the revenues showcasing 18.99% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 28.46M, as it employees total of 10 workers.
AzurRx BioPharma Inc. (AZRX) in the eye of market guru’s
During the last month, 0 analysts gave the AzurRx BioPharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.7787, with a change in the price was noted +0.0325. In a similar fashion, AzurRx BioPharma Inc. posted a movement of +3.65% for the period of last 100 days, recording 504,859 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AZRX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
AzurRx BioPharma Inc. (AZRX): Stocks Technical analysis and Trends
Raw Stochastic average of AzurRx BioPharma Inc. in the period of last 50 days is set at 57.38%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 50.64%. In the last 20 days, the company’s Stochastic %K was 32.30% and its Stochastic %D was recorded 27.65%.
If we look into the earlier routines of AzurRx BioPharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -4.90%. Additionally, trading for the stock in the period of the last six months notably improved by 9.95%, alongside a downfall of -46.37% for the period of the last 12 months. The shares increased approximately by 2.50% in the 7-day charts and went down by 21.33% in the period of the last 30 days. Common stock shares were driven by 18.99% during last recorded quarter.